Nanoparticulate candesartan formulations
A nanoparticle, candesartan technology, applied in the direction of nanotechnology, nanotechnology, nanomedicine, etc., can solve the problem that the circulation level of angiotensin II does not exceed the effect of blood pressure
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0026] The present invention relates to nanoparticulate compositions comprising candesartan (eg, candesartan cilexetil). The composition comprises: nanoparticulate candesartan particles having an effective average particle size of less than about 2000 nm, and at least one surface stabilizer.
[0027] As taught in the '684 patent, and as illustrated in the examples below, not all combinations of surface stabilizers and actives will result in stable nanoparticle compositions. However, it was surprisingly found that stable nanoparticulate candesartan formulations could be prepared.
[0028] Advantages of the nanoparticulate candesartan formulations of the present invention include, but are not limited to: (1) smaller size in tablets or other solid dosage forms; (3) the bioavailability is improved compared with the conventional form of candesartan; (4) the pharmacokinetic profile is improved; (5) the bioequivalence of the nanoparticulate candesartan composition is improved (6) t...
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
size | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com